Design, synthesis and anti-diabetic activity of novel 1, 2, 3-triazole-5-carboximidamide derivatives as dipeptidyl peptidase-4 inhibitors
作者:Hossein Fasihi Dastjerdi、Nima Naderi、Manijeh Nematpour、Elham Rezaee、Mohammad Mahboubi-Rabbani、Melika Ebrahimi、Samaneh Hosseinipoor、Omid Hosseini、Sayyed Abbas Tabatabai
DOI:10.1016/j.molstruc.2020.128745
日期:2020.12
the treatment of type 2 diabetes mellitus. In this study, a novel series of 1, 2, 3-triazole-5-carboximidamide derivatives were designed, synthesized, and inhibitory activity evaluated against the DPP-4 enzyme. All of the compounds represented inhibitory activity, and among them, compounds 6a, 6b, and 6c showed desirable inhibitory activity of DPP-4 with IC50 values of 14.75 nM, 6.75 nM, and 6.57 nM
摘要 4 型二肽基肽酶 (DPP-4) 抑制剂作为一种有效的胰岛素分泌刺激剂和胰腺分泌胰高血糖素的抑制剂,已被认为是治疗 2 型糖尿病的有前途的药物。在这项研究中,设计、合成了一系列新的 1, 2, 3-triazole-5-carboximidamide 衍生物,并评估了对 DPP-4 酶的抑制活性。所有化合物均表现出抑制活性,其中化合物6a、6b和6c显示出理想的DPP-4抑制活性,IC50值分别为14.75 nM、6.75 nM和6.57 nM。在 NMRI 小鼠的 OGTT 期间,10 mg/kg 剂量的化合物 6a 显示葡萄糖耐量增强。而且,